In conclusion, we have shown that expression of p52, a major mediator of non-canonical NF-κB signaling, is an important prognostic factor for high-grade serous ovarian cancer, and that this association is independent of canonical NF-κB signaling through p65. This evidence concerns the gene NFKB2 and ovarian serous adenocarcinoma.